Dezhi Song

机构：Guangxi Medical University, Tianjin University, First Affiliated Hospital of GuangXi Medical University, East China Normal University · ORCID：0000-0001-9431-5182

发表论文 52 篇 · 总被引 976 次 · h-index 16

代表论文

• Pharmacology-based molecular docking of 4-methylcatechol and its role in RANKL-mediated ROS/Keap1/Nrf2 signalling axis and osteoclastogenesis (2023 · Biomedicine & Pharmacotherapy · 被引 49)
• Isosinensetin alleviates estrogen deficiency-induced osteoporosis via suppressing ROS-mediated NF-κB/MAPK signaling pathways (2023 · Biomedicine & Pharmacotherapy · 被引 34)
• Single-cell RNA sequencing reveals differential expression of EGFL7 and VEGF in giant-cell tumor of bone and osteosarcoma (2022 · Experimental Biology and Medicine · 被引 31)
• Corylifol A protects against ovariectomized-induced bone loss and attenuates RANKL‐induced osteoclastogenesis via ROS reduction, ERK inhibition, and NFATc1 activation (2023 · Free Radical Biology and Medicine · 被引 21)
• Single-Cell Transcriptome Analysis Reveals Paraspeckles Expression in Osteosarcoma Tissues (2022 · Cancer Informatics · 被引 19)
• AKT/GSK3β/NFATc1 and ROS signal axes are involved in AZD1390-mediated inhibitory effects on osteoclast and OVX-induced osteoporosis (2022 · International Immunopharmacology · 被引 17)